Biogen Launches Study to Find Out if Apple Watch and iPhone Can Detect Declining Cognitive Health
Biotechnology company Biogen today announced the launch of a new Apple Watch study in partnership with Apple that is aimed at investigating the role the iPhone and Apple Watch might play in monitoring cognitive performance and screening for decline in cognitive health.
The multi-year study will launch later this year and will enroll both young and aging adults with a range of cognitive performance. The study's objectives are to find digital biomarkers for helping to monitor cognitive performance over time and identifying early signs of mild cognitive impairment.
Mild cognitive impairment impacts approximately 15 to 20 percent of adults over the age of 64, and the onset of symptoms are often subtle, so it can take months or even years before health care providers become aware of the problem.
"Working in collaboration with Biogen, we hope this study can help the medical community better understand a person's cognitive performance by simply having them engage with their Apple Watch and iPhone," said Jeff Williams, Apple's chief operating officer. "We're looking forward to learning about the impact our technology can have in delivering better health outcomes through improved detection of declining cognitive health."
The study will be privacy-focused with customer control, transparency, and data security in mind. Participants will be offered a detailed consent form listing the data types collected and how that data may be used and shared. Data is stored encrypted and in systems with strong security controls.
Popular Stories
Apple today unveiled redesigned iPad Pro models featuring the M4 chip, Ultra Retina XDR OLED displays, a nano-texture display option, and more. The new iPad Pro offers a considerably thinner design and slightly larger 11- and 13-inch display size options. The 11-inch model is 5.3mm thick and weighs less than a pound, while the 13-inch model is just 5.1mm thick and weighs a quarter pound less ...
Apple's "Let Loose" event kicks off today at the unusual time of 7:00 a.m. Pacific Time, and we're expecting to see an iPad-focused event with new iPad Pro and iPad Air models, updated Apple Pencil and Magic Keyboard accessories, and perhaps some other announcements. Apple is providing a live video stream on its website, on YouTube, and in the company's TV app across various platforms. We...
Apple today announced that iOS 17.5 will be released to the public "soon," following over a month of beta testing. While the software update is relatively minor, it does have a few new features and changes, as outlined in the list below. "The new Pride Radiance watch face and iPhone and iPad wallpapers will be available soon with watchOS 10.5, iOS 17.5, and iPadOS 17.5," said Apple, in its...
Apple at its "Let Loose" event today announced a new Magic Keyboard for the latest iPad Pro models, with a thinner, lighter design. Apple says the Magic Keyboard has been redesigned to be thinner and lighter, while maintaing the same floating design. Two colors are available that match the new iPad Pro. New features include a function row with screen brightness controls, an aluminum...
Apple today held the first event of 2024, debuting new iPad Air and iPad Pro models and accompanying accessories. While the event was faster than normal and took 40 minutes, we've condensed it down even further for those who want a quick overview of everything that was announced. Subscribe to the MacRumors YouTube channel for more videos. We've also got a full recap of all of the coverage...
While the iPhone 16 series is still months away from launching, an early rumor about an all-new iPhone 17 model has now surfaced. In a research note with investment firm Haitong this week, analyst Jeff Pu said Apple is planning a so-called "iPhone 17 Slim" model that would replace the Plus model in the lineup. Pu said this model will feature around a 6.6-inch display, a slimmer design, an...
Top Rated Comments
My suspicion is that they do - I think / wait- I'm not sure- what was I saying? - oh never mind
Frankly I'm interested in why Biogen in particular is doing this study given that they're not testing any new drugs with this, and not any other researchers.